Longeveron Inc.
USD0.69
-0.01 (-2.10%)
CEO
Stephen H. Willard
IPO Date
2021-02-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.73
Prev. Close
$0.71
Day Low
$0.69
Day High
$0.75
52W Low
$0.47
52W High
$1.80
Market Cap
$0.01B
Volume
0.26M
| -1.6 |
| 31 Dec 2023 | FY | 31.2% | -3020.2% | -317.7% | -177.3% | 0.30 | 1.50 | -1.4 |
| 31 Dec 2022 | FY | 40.7% | -1541.3% | -91.9% | -68.7% | 0.13 | 4.17 | -3.6 |
| 31 Dec 2021 | FY | 45.2% | -1305.1% | -45.5% | -39.9% | 0.08 | 13.06 | -13.4 |
| 31 Dec 2020 | FY | 32.4% | -66.1% | -190.1% | -40.3% | 2.12 | 0.48 | -33.6 |
| 31 Dec 2019 | FY | 32.4% | -66.1% | -83.7% | -35.2% | 0.93 | 0.95 | -31.9 |
| 31 Dec 2018 | FY | 31.9% | -296.8% | -93.0% | -60.2% | 0.00 | 2.24 | -18.6 |
| -0.5 |
| 30 Sept 2025 | Q3 | 91.2% | -5270.8% | -72.5% | -46.4% | 0.10 | 2.09 | -0.5 |
| 30 Jun 2025 | Q2 | 46.2% | -1591.1% | -39.7% | -30.0% | 0.09 | 3.43 | -1.0 |
| 31 Mar 2025 | Q1 | 72.2% | -1315.2% | -29.2% | -24.0% | 0.08 | 5.61 | -1.2 |
| 31 Dec 2024 | Q4 | 87.9% | -676.8% | -18.6% | -16.0% | 0.07 | 7.60 | -1.6 |
| 30 Sept 2024 | Q3 | 88.2% | -571.7% | -17.2% | -14.8% | 0.06 | 7.67 | -1.5 |
| 30 Jun 2024 | Q2 | 73.5% | -729.3% | -22.9% | -17.6% | 0.12 | 4.18 | -0.7 |
| 31 Mar 2024 | Q1 | 60.0% | -740.5% | -133.4% | -41.8% | 0.62 | 0.71 | -0.4 |
| 31 Dec 2023 | Q4 | -3.2% | -9568.3% | -89.4% | -49.9% | 0.30 | 1.50 | 0.0 |